Cargando…

Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies

Whilst it is highly desirable to produce artificial lipid bilayer arrays allowing for systematic high-content screening of membrane conditions, it remains a challenge due to the combined requirements of scaled membrane production, simple measurement access, and independent control over individual bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxani, D. K., Jamieson, W. D., Barrow, D. A., Castell, O. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277618/
https://www.ncbi.nlm.nih.gov/pubmed/35766018
http://dx.doi.org/10.1039/d1sm01111a
_version_ 1784746022986055680
author Baxani, D. K.
Jamieson, W. D.
Barrow, D. A.
Castell, O. K.
author_facet Baxani, D. K.
Jamieson, W. D.
Barrow, D. A.
Castell, O. K.
author_sort Baxani, D. K.
collection PubMed
description Whilst it is highly desirable to produce artificial lipid bilayer arrays allowing for systematic high-content screening of membrane conditions, it remains a challenge due to the combined requirements of scaled membrane production, simple measurement access, and independent control over individual bilayer experimental conditions. Here, droplet bilayers encapsulated within a hydrogel shell are output individually into multi-well plates for simple, arrayed quantitative measurements. The afforded experimental throughput is used to conduct a 2D concentration screen characterising the synergistic pore-forming peptides Magainin2 and PGLa. Maximal enhanced activity is revealed at equimolar peptide concentrations via a membrane dye leakage assay, a finding consistent with models proposed from NMR data. The versatility of the platform is demonstrated by performing in situ electrophysiology, revealing low conductance pore activity (∼15 to 20 pA with 4.5 pA sub-states). In conclusion, this array platform addresses the aforementioned challenges and provides new and flexible opportunities for high-throughput membrane studies. Furthermore, the ability to engineer droplet networks within each construct paves the way for “lab-in-a-capsule” approaches accommodating multiple assays per construct and allowing for communicative reaction pathways.
format Online
Article
Text
id pubmed-9277618
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-92776182022-08-01 Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies Baxani, D. K. Jamieson, W. D. Barrow, D. A. Castell, O. K. Soft Matter Chemistry Whilst it is highly desirable to produce artificial lipid bilayer arrays allowing for systematic high-content screening of membrane conditions, it remains a challenge due to the combined requirements of scaled membrane production, simple measurement access, and independent control over individual bilayer experimental conditions. Here, droplet bilayers encapsulated within a hydrogel shell are output individually into multi-well plates for simple, arrayed quantitative measurements. The afforded experimental throughput is used to conduct a 2D concentration screen characterising the synergistic pore-forming peptides Magainin2 and PGLa. Maximal enhanced activity is revealed at equimolar peptide concentrations via a membrane dye leakage assay, a finding consistent with models proposed from NMR data. The versatility of the platform is demonstrated by performing in situ electrophysiology, revealing low conductance pore activity (∼15 to 20 pA with 4.5 pA sub-states). In conclusion, this array platform addresses the aforementioned challenges and provides new and flexible opportunities for high-throughput membrane studies. Furthermore, the ability to engineer droplet networks within each construct paves the way for “lab-in-a-capsule” approaches accommodating multiple assays per construct and allowing for communicative reaction pathways. The Royal Society of Chemistry 2022-06-17 /pmc/articles/PMC9277618/ /pubmed/35766018 http://dx.doi.org/10.1039/d1sm01111a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Baxani, D. K.
Jamieson, W. D.
Barrow, D. A.
Castell, O. K.
Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
title Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
title_full Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
title_fullStr Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
title_full_unstemmed Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
title_short Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
title_sort encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277618/
https://www.ncbi.nlm.nih.gov/pubmed/35766018
http://dx.doi.org/10.1039/d1sm01111a
work_keys_str_mv AT baxanidk encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies
AT jamiesonwd encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies
AT barrowda encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies
AT castellok encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies